Literature DB >> 27115427

Clickable Photoaffinity Ligands for Metabotropic Glutamate Receptor 5 Based on Select Acetylenic Negative Allosteric Modulators.

Karen J Gregory1, Ranganadh Velagaleti2, David M Thal1, Ryan M Brady1, Arthur Christopoulos1, P Jeffrey Conn3, David J Lapinsky2.   

Abstract

G protein-coupled receptors (GPCRs) represent the largest class of current drug targets. In particular, small-molecule allosteric modulators offer substantial potential for selectively "tuning" GPCR activity. However, there remains a critical need for experimental strategies that unambiguously determine direct allosteric ligand-GPCR interactions, to facilitate both chemical biology studies and rational structure-based drug design. We now report the development and use of first-in-class clickable allosteric photoprobes for a GPCR based on metabotropic glutamate receptor 5 (mGlu5) negative allosteric modulator (NAM) chemotypes. Select acetylenic mGlu5 NAM lead compounds were rationally modified to contain either a benzophenone or an aryl azide as a photoreactive functional group, enabling irreversible covalent attachment to mGlu5 via photoactivation. Additionally, a terminal alkyne or an aliphatic azide was incorporated as a click chemistry handle, allowing chemoselective attachment of fluorescent moieties to the irreversibly mGlu5-bound probe via tandem photoaffinity labeling-bioorthogonal conjugation. These clickable photoprobes retained submicromolar affinity for mGlu5 and negative cooperativity with glutamate, interacted with the "common allosteric-binding site," displayed slow binding kinetics, and could irreversibly label mGlu5 following UV exposure. We depleted the number of functional mGlu5 receptors using an irreversibly bound NAM to elucidate and delineate orthosteric agonist affinity and efficacy. Finally, successful conjugation of fluorescent dyes via click chemistry was demonstrated for each photoprobe. In the future, these clickable photoprobes are expected to aid our understanding of the structural basis of mGlu5 allosteric modulation. Furthermore, tandem photoaffinity labeling-bioorthogonal conjugation is expected to be a broadly applicable experimental strategy across the entire GPCR superfamily.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27115427      PMCID: PMC4981245          DOI: 10.1021/acschembio.6b00026

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  37 in total

1.  Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activity.

Authors:  Jeffrey Roppe; Nicholas D Smith; Dehua Huang; Lida Tehrani; Bowei Wang; Jeffrey Anderson; Jesse Brodkin; Janice Chung; Xiaohui Jiang; Christopher King; Benito Munoz; Mark A Varney; Petpiboon Prasit; Nicholas D P Cosford
Journal:  J Med Chem       Date:  2004-09-09       Impact factor: 7.446

2.  Microscopic visualization of metabotropic glutamate receptors on the surface of living cells using bifunctional magnetic resonance imaging probes.

Authors:  Anurag Mishra; Ritu Mishra; Sven Gottschalk; Robert Pal; Neil Sim; Joern Engelmann; Martin Goldberg; David Parker
Journal:  ACS Chem Neurosci       Date:  2013-11-27       Impact factor: 4.418

3.  Efficacy switching SAR of mGluR5 allosteric modulators: highly potent positive and negative modulators from one chemotype.

Authors:  Anette Graven Sams; Gitte Kobberøe Mikkelsen; Robbin M Brodbeck; Xiaosui Pu; Andreas Ritzén
Journal:  Bioorg Med Chem Lett       Date:  2011-04-05       Impact factor: 2.823

Review 4.  Structures of mGluRs shed light on the challenges of drug development of allosteric modulators.

Authors:  Kirstie A Bennett; Andrew S Doré; John A Christopher; Dahlia R Weiss; Fiona H Marshall
Journal:  Curr Opin Pharmacol       Date:  2014-10-17       Impact factor: 5.547

5.  Synthesis and pharmacological evaluation of analogues of benzyl quinolone carboxylic acid (BQCA) designed to bind irreversibly to an allosteric site of the M ₁ muscarinic acetylcholine receptor.

Authors:  Briana J Davie; Celine Valant; Jonathan M White; Patrick M Sexton; Ben Capuano; Arthur Christopoulos; Peter J Scammells
Journal:  J Med Chem       Date:  2014-06-05       Impact factor: 7.446

6.  Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator.

Authors:  Huixian Wu; Chong Wang; Karen J Gregory; Gye Won Han; Hyekyung P Cho; Yan Xia; Colleen M Niswender; Vsevolod Katritch; Jens Meiler; Vadim Cherezov; P Jeffrey Conn; Raymond C Stevens
Journal:  Science       Date:  2014-03-06       Impact factor: 47.728

7.  [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization.

Authors:  Jeffery J Anderson; Sara P Rao; Blake Rowe; Darlene R Giracello; Greg Holtz; Deborah F Chapman; Lida Tehrani; Margaret J Bradbury; Nicholas D P Cosford; Mark A Varney
Journal:  J Pharmacol Exp Ther       Date:  2002-12       Impact factor: 4.030

8.  Structure-activity relationships of fluorinated (E)-3-((6-methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyloxime (ABP688) derivatives and the discovery of a high affinity analogue as a potential candidate for imaging metabotropic glutamate recepors subtype 5 (mGluR5) with positron emission tomography (PET).

Authors:  Cindy A Baumann; Linjing Mu; Sinja Johannsen; Michael Honer; Pius A Schubiger; Simon M Ametamey
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

Review 9.  Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders.

Authors:  P Jeffrey Conn; Craig W Lindsley; Jens Meiler; Colleen M Niswender
Journal:  Nat Rev Drug Discov       Date:  2014-09       Impact factor: 84.694

10.  Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.

Authors:  Aashish Manglik; Andrew C Kruse; Tong Sun Kobilka; Foon Sun Thian; Jesper M Mathiesen; Roger K Sunahara; Leonardo Pardo; William I Weis; Brian K Kobilka; Sébastien Granier
Journal:  Nature       Date:  2012-03-21       Impact factor: 49.962

View more
  7 in total

1.  Click Chemistry Reagent for Identification of Sites of Covalent Ligand Incorporation in Integral Membrane Proteins.

Authors:  Melissa M Budelier; Wayland W L Cheng; Lucie Bergdoll; Zi-Wei Chen; Jeff Abramson; Kathiresan Krishnan; Mingxing Qian; Douglas F Covey; James W Janetka; Alex S Evers
Journal:  Anal Chem       Date:  2017-02-09       Impact factor: 6.986

Review 2.  Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.

Authors:  David R Janero; Ganesh A Thakur
Journal:  Expert Opin Drug Discov       Date:  2016-10-21       Impact factor: 6.098

3.  Developing Photoaffinity Probes for Dopamine Receptor D2 to Determine Targets of Parkinson's Disease Drugs.

Authors:  Spencer T Kim; Emma J Doukmak; Raymond G Flax; Dylan J Gray; Victoria N Zirimu; Ebbing de Jong; Rachel C Steinhardt
Journal:  ACS Chem Neurosci       Date:  2022-10-02       Impact factor: 5.780

4.  Selective Photoaffinity Probe That Enables Assessment of Cannabinoid CB2 Receptor Expression and Ligand Engagement in Human Cells.

Authors:  Marjolein Soethoudt; Sara C Stolze; Matthias V Westphal; Luuk van Stralen; Andrea Martella; Eva J van Rooden; Wolfgang Guba; Zoltan V Varga; Hui Deng; Sander I van Kasteren; Uwe Grether; Adriaan P IJzerman; Pal Pacher; Erick M Carreira; Herman S Overkleeft; Andreea Ioan-Facsinay; Laura H Heitman; Mario van der Stelt
Journal:  J Am Chem Soc       Date:  2018-02-16       Impact factor: 15.419

5.  Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization.

Authors:  Maarten L J Doornbos; Xuesong Wang; Sophie C Vermond; Luc Peeters; Laura Pérez-Benito; Andrés A Trabanco; Hilde Lavreysen; José María Cid; Laura H Heitman; Gary Tresadern; Adriaan P IJzerman
Journal:  J Med Chem       Date:  2018-03-07       Impact factor: 7.446

Review 6.  Molecular probes for the human adenosine receptors.

Authors:  Xue Yang; Laura H Heitman; Adriaan P IJzerman; Daan van der Es
Journal:  Purinergic Signal       Date:  2020-12-12       Impact factor: 3.765

7.  An Affinity-Based Probe for the Human Adenosine A2A Receptor.

Authors:  Xue Yang; Thomas J M Michiels; Coen de Jong; Marjolein Soethoudt; Niek Dekker; Euan Gordon; Mario van der Stelt; Laura H Heitman; Daan van der Es; Adriaan P IJzerman
Journal:  J Med Chem       Date:  2018-08-21       Impact factor: 7.446

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.